A detailed history of Eqis Capital Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 18,277 shares of NVO stock, worth $1.97 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
18,277
Previous 19,335 5.47%
Holding current value
$1.97 Million
Previous $2.76 Million 21.13%
% of portfolio
0.18%
Previous 0.24%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $125,976 - $153,854
-1,058 Reduced 5.47%
18,277 $2.18 Million
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $512,805 - $613,936
-4,179 Reduced 17.77%
19,335 $2.76 Million
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $478,895 - $637,464
-4,690 Reduced 16.63%
23,514 $3.02 Million
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $417,218 - $501,203
4,753 Added 20.27%
28,204 $2.92 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $2.13 Million - $4.68 Million
23,451 New
23,451 $2.13 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $1.03 Million - $1.24 Million
7,813 New
7,813 $1.24 Million
Q2 2022

Aug 08, 2022

SELL
$103.24 - $121.81 $252,421 - $297,825
-2,445 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $227,629 - $275,160
2,445 New
2,445 $272,000
Q1 2021

May 14, 2021

SELL
$67.06 - $75.82 $342,207 - $386,909
-5,103 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$63.89 - $73.8 $28,558 - $32,988
-447 Reduced 8.05%
5,103 $356,000
Q3 2020

Nov 10, 2020

SELL
$63.69 - $70.22 $57,193 - $63,057
-898 Reduced 13.93%
5,550 $385,000
Q2 2020

Aug 10, 2020

BUY
$58.54 - $67.94 $180,771 - $209,798
3,088 Added 91.9%
6,448 $422,000
Q1 2020

May 12, 2020

SELL
$49.46 - $64.78 $62,863 - $82,335
-1,271 Reduced 27.45%
3,360 $212,000
Q4 2019

Jan 24, 2020

SELL
$49.86 - $58.26 $27,871 - $32,567
-559 Reduced 10.77%
4,631 $268,000
Q3 2019

Nov 05, 2019

SELL
$47.54 - $53.43 $1,663 - $1,870
-35 Reduced 0.67%
5,190 $268,000
Q2 2019

Jul 18, 2019

SELL
$46.79 - $52.47 $90,304 - $101,267
-1,930 Reduced 26.97%
5,225 $267,000
Q1 2019

Apr 18, 2019

BUY
$46.36 - $52.63 $8,344 - $9,473
180 Added 2.58%
7,155 $374,000
Q4 2018

Jan 25, 2019

SELL
$41.54 - $47.25 $8,308 - $9,450
-200 Reduced 2.79%
6,975 $321,000
Q3 2018

Oct 17, 2018

SELL
$46.76 - $51.24 $6,593 - $7,224
-141 Reduced 1.93%
7,175 $350,000
Q2 2018

Jul 27, 2018

SELL
$44.29 - $50.42 $14,837 - $16,890
-335 Reduced 4.38%
7,316 $337,000
Q1 2018

Apr 06, 2018

SELL
$48.49 - $58.14 $38,016 - $45,581
-784 Reduced 9.29%
7,651 $377,000
Q4 2017

Jan 25, 2018

SELL
$47.53 - $53.73 $50,476 - $57,061
-1,062 Reduced 11.18%
8,435 $453,000
Q3 2017

Oct 03, 2017

BUY
$41.15 - $49.22 $390,801 - $467,442
9,497
9,497 $457,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.